Dexmedetomidine and Vasopressin in Septic Shock

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
Rudiger and Singer suggested strategies for refining adrenergic stress (decatecholaminization). They proposed the use of dexmedetomidine and vasopressin to reduce the catecholamine load during sepsis. The investigators will use vasopressin as the primary vasopressor and a heart rate-calibrated dexmedetomidine infusion in septic shock patients. The investigators of the current study will use DEXPRESSIN in septic shock patients to investigate the effects of decatecholaminization on in-hospital mortality.
Epistemonikos ID: bd0464b51c7a00e65e56dbd603a58f96ac96c556
First added on: May 15, 2024